Progress in Treating Youth Smoking: Imperative, Difficult, Slow

Bolstering FDA Pathways for Reducing Death and Disease from Tobacco

“…These concerns are especially heightened for children. 3 The experience with Juul, a vaping product that was inappropriately marketed and fueled a youth vaping crisis in 2018, without MRTP authorization, underscores the risks associated with these products. 4 Reflecting these concerns, the FDA has been cautious in granting MRTP authorizations, and the pathway for demonstrating that a product meets the strict standards is challenging.…”

“…Although alternative nicotine delivery systems might reduce harm for existing smokers, they also carry the risk of initiating new nicotine users, some of whom may eventually transition to combustible tobacco. These concerns are especially heightened for children . The experience with Juul, a vaping product that was inappropriately marketed and fueled a youth vaping crisis in 2018, without MRTP authorization, underscores the risks associated with these products…”